论文信息 - The routes to orphan drug designation--our recent experience at the FDA. - 字舞流文

The routes to orphan drug designation--our recent experience at the FDA.

Menfo A Imoisili | Daniel Lev | Chandana Thorat | Ian Phillips | Mathew Thomas

[1] Timothy R. Coté,et al. Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years , 2010, Nature Reviews Drug Discovery.